Schwarz, E. M. et al. 2018 International Consensus Meeting on musculoskeletal infection: research priorities from the general assembly questions. J. Orthop. Res. 37, 997–1006 (2019).
Tande, A. J. & Patel, R. Prosthetic joint infection. Clin. Microbiol Rev. 27, 302–345 (2014).
PubMed PubMed Central Article CAS Google Scholar
Stulberg, J. J. et al. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 303, 2479–2485 (2010).
CAS PubMed Article Google Scholar
Masters, E. A. et al. Skeletal infections: microbial pathogenesis, immunity and clinical management. Nat. Rev. Microbiol. 20, 385–400 (2022). https://doi.org/10.1038/s41579-022-00686-0.
Kates, S. L. & Tornetta, P. 3rd Commentary on secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition originally published in the Journal of Bone and Mineral Research. J. Orthop. Trauma 34, 221 (2020).
Goodson, K. M. et al. Streamlining hospital treatment of prosthetic joint infection. J. Arthroplast. 35, S63–S68 (2020).
Depypere, M. et al. Pathogenesis and management of fracture-related infection. Clin. Microbiol Infect. 26, 572–578 (2020).
CAS PubMed Article Google Scholar
Govaert, G. A. M. et al. Diagnosing fracture-related infection: current concepts and recommendations. J. Orthop. Trauma 34, 8–17 (2020).
Kandel, C. E. et al. Predictors of treatment failure for hip and knee prosthetic joint infections in the setting of 1- and 2-stage exchange arthroplasty: a multicenter retrospective cohort. Open Forum Infect. Dis. 6, ofz452 (2019).
PubMed PubMed Central Article Google Scholar
Masters, E. A. et al. Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy”. Bone Res. 7, 20 (2019).
PubMed PubMed Central Article CAS Google Scholar
Kaplan, S. L. Recent lessons for the management of bone and joint infections. J. Infect. 68, S51–S56 (2014).
Assis, L. M., Nedeljkovic, M. & Dessen, A. New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus. Drug Resist. Updat. 31, 1–14 (2017).
Weigelt, J. A. et al. Surgical site infections: causative pathogens and associated outcomes. Am. J. Infect. Control 38, 112–120 (2010).
van Hal, S. J. et al. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin. Microbiol. Rev. 25, 362–386 (2012).
PubMed PubMed Central Article CAS Google Scholar
Wong, H. R., Lindsell, C. J., Lahni, P., Hart, K. W. & Gibot, S. Interleukin 27 as a sepsis diagnostic biomarker in critically ill adults. Shock 40, 382–386 (2013).
CAS PubMed PubMed Central Article Google Scholar
Wong, H. R., Liu, K. D., Kangelaris, K. N., Lahni, P. & Calfee, C. S. Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults. J. Crit. Care 29, 718–722 (2014).
CAS PubMed PubMed Central Article Google Scholar
Hanna, W. J., Berrens, Z., Langner, T., Lahni, P. & Wong, H. R. Interleukin-27: a novel biomarker in predicting bacterial infection among the critically ill. Crit. Care 19, 378 (2015).
PubMed PubMed Central Article Google Scholar
He, Y. et al. Multiplex cytokine profiling identifies interleukin-27 as a novel biomarker for neonatal early onset sepsis. Shock 47, 140–147 (2017).
CAS PubMed Article Google Scholar
Jacobs, L. et al. Interleukin-27 as a candidate diagnostic biomarker for bacterial infection in immunocompromised pediatric patients. PLoS One 13, e0207620 (2018).
PubMed PubMed Central Article CAS Google Scholar
Wong HR, C. N. et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Crit. Care 16, R213 (2012).
PubMed PubMed Central Article Google Scholar
Yoshida, H. & Hunter, C. A. The immunobiology of interleukin-27. Annu Rev. Immunol. 33, 417–443 (2015).
CAS PubMed Article Google Scholar
Hunter, C. A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521–531 (2005).
CAS PubMed Article Google Scholar
Morita, Y., Masters, E. A., Schwarz, E. M. & Muthukrishnan, G. Interleukin-27 and its diverse effects on bacterial infections. Front. Immunol. 12, 678515 (2021).
CAS PubMed PubMed Central Article Google Scholar
Diveu, C. et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 182, 5748–5756 (2009).
CAS PubMed Article Google Scholar
Hall, A. O. et al. The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37, 511–523 (2012).
PubMed PubMed Central Article CAS Google Scholar
Cao, J. et al. IL-27 controls sepsis-induced impairment of lung antibacterial host defence. Thorax 69, 926–937 (2014).
Robinson, K. M. et al. The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia. Respir. Res. 16, 10 (2015).
CAS PubMed PubMed Central Article Google Scholar
Seita, J. et al. Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood 111, 1903–1912 (2008).
CAS PubMed Article Google Scholar
Pflanz, S. et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225–2231 (2004).
CAS PubMed Article Google Scholar
Guzzo, C., Che Mat, N. F. & Gee, K. Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. J. Biol. Chem. 285, 24404–24411 (2010).
CAS PubMed PubMed Central Article Google Scholar
Lucas, S., Ghilardi, N., Li, J. & de Sauvage, F. J. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 100, 15047–15052 (2003).
CAS PubMed PubMed Central Article Google Scholar
Nishitani, K. et al. Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors. J. Orthop. Res. 33, 1311–1319 (2015).
PubMed PubMed Central Article Google Scholar
Masters, E. A. et al. Identification of Penicillin Binding Protein 4 (PBP4) as a critical factor for Staphylococcus aureus bone invasion during osteomyelitis in mice. PLoS Pathog. 16, e1008988 (2020).
CAS PubMed PubMed Central Article Google Scholar
Nishitani, K. et al. IsdB antibody-mediated sepsis following S. aureus surgical site infection. JCI Insight 5, e141164 (2020).
Masters, E. A. et al. Distinct vasculotropic versus osteotropic features of S. agalactiae versus S. aureus implant-associated bone infection in mice. J. Orthop. Res. 39, 389–401 (2021).
CAS PubMed Article Google Scholar
Varrone, J. J. et al. Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters. J. Orthop. Res. 32, 1389–1396 (2014).
CAS PubMed PubMed Central Article Google Scholar
Frangieh, M. et al. IL-27: an endogenous constitutive repressor of human monocytes. Clin. Immunol. 217, 108498 (2020).
CAS PubMed PubMed Central Article Google Scholar
Ivanov, I. I. et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper. Cells Cell 126, 1121–1133 (2006).
CAS PubMed Article Google Scholar
Fan, J. et al. IL-27 is elevated in sepsis with acute hepatic injury and promotes hepatic damage and inflammation in the CLP model. Cytokine 127, 154936 (2020).
CAS PubMed Article Google Scholar
Ellington, J. K. et al. Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis. J. Bone Jt. Surg. Br. 85, 918–921 (2003).
Ellington, J. K. et al. Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis. J. Orthop. Res. 24, 87–93 (2006).
留言 (0)